Surgical evaluation in children <3 years of age with drug-resistant epilepsy: Patient characteristics, diagnostic utilization, and potential for treatment delays.


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
01 2022
Historique:
revised: 06 10 2021
received: 28 05 2021
accepted: 02 11 2021
pubmed: 16 11 2021
medline: 21 4 2022
entrez: 15 11 2021
Statut: ppublish

Résumé

Drug-resistant epilepsy (DRE) occurs at higher rates in children <3 years old. Epilepsy surgery is effective, but rarely utilized in young children despite developmental benefits of early seizure freedom. The present study aims to identify unique patient characteristics and evaluation strategies in children <3 years old who undergo epilepsy surgery evaluation as a means to assess contributors and potential solutions to health care disparities in this group. The Pediatric Epilepsy Research Consortium Epilepsy Surgery Database, a multicentered, cross-sectional collaboration of 21 US pediatric epilepsy centers, collects prospective data on children <18 years of age referred for epilepsy surgery evaluation. We compared patient characteristics, diagnostic utilization, and surgical treatment between children <3 years old and those older undergoing initial presurgical evaluation. We evaluated patient characteristics leading to delayed referral (>1 year) after DRE diagnosis in the very young. The cohort included 437 children, of whom 71 (16%) were <3 years of age at referral. Children evaluated before the age of 3 years more commonly had abnormal neurological examinations (p = .002) and daily seizures (p = .001). At least one ancillary test was used in 44% of evaluations. Fifty-nine percent were seizure-free following surgery (n = 34), with 35% undergoing limited focal resections. Children with delayed referrals more often had focal aware (p < .001) seizures and recommendation for palliative surgeries (p < .001). There are relatively few studies of epilepsy surgery in the very young. Surgery is effective, but may be disproportionally offered to those with severe presentations. Relatively low utilization of ancillary testing may contribute to reduced surgical therapy for those without evident lesions on magnetic resonance imaging. Despite this, a sizeable portion of patients have favorable outcome after focal epilepsy surgery resections.

Identifiants

pubmed: 34778945
doi: 10.1111/epi.17124
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

96-107

Informations de copyright

© 2021 International League Against Epilepsy.

Références

Camfield CS, Camfield PR, Gordon K, Wirrell E, Dooley JM. Incidence of epilepsy in childhood and adolescence: a population-based study in Nova Scotia from 1977 to 1985. Epilepsia. 1996;37:19-23.
Wirrell EC, Grossardt BR, Wong-Kisiel LC, Nickels KC. Incidence and classification of new-onset epilepsy and epilepsy syndromes in children in Olmsted County, Minnesota from 1980 to 2004: a population-based study. Epilepsy Res. 2011;95:110-8.
Aabert KM, Gunnes N, Bakken IJ, Søraas CL, Berntsen A, Magnus P, et al. Incidence and prevalence of childhood epilepsy: a nationwide cohort study. Pediatrics. 2017;139:1-9.
Vignoli A, Peron A, Turner K, Scornavacca GF, La Briola F, Chiesa V, et al. Long-term outcome of epilepsy with onset in the first three years of life: findings from a large cohort of patients. Eur J Paediatr Neurol. 2016;20:566-72.
Berg AT, Zelko FA, Levy SR, Testa FM. Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes: a prospective cohort study. Neurology. 2012;79:1384-91.
Berg AT, Wusthoff C, Shellhaas RA, Loddenkemper T, Grinspan ZM, Saneto RP, et al. Immediate outcomes in early life epilepsy: a contemporary account. Epilepsy Behav. 2019;97:44-50.
Wirrell E, Wong-Kisiel L, Mandrekar J, Nickels K. Predictors and course of medically intractable epilepsy in young children presenting before 36 months of age: a retrospective, population-based study. Epilepsia. 2012;53:1563-9.
Baud MO, Perneger T, Racz A, Pensel MC, Elger C, Rydenhag B, et al. European trends in epilepsy surgery. Neurology. 2018;91:96-106.
Duchowny M, Jayakar P, Resnick T, Harvey AS, Alvarez L, Dean P, et al. Epilepsy surgery in the first three years of life. Epilepsia. 1998;39:737-43.
Jenny B, Smoll N, El Hassani Y, Momjian S, Pollo C, Korff CM, et al. Pediatric epilepsy surgery: could age be a predictor of outcomes? J Neurosurg Pediatr. 2016;18:235-41.
Loddenkemper T, Holland KD, Stanford LD, Kotagal P, Bingaman W, Wyllie E. Developmental outcome after epilepsy surgery in infancy. Pediatrics. 2007;119:930-5.
Pindrik J, Hoang N, Smith L, Halverson M, Wojnaroski M, McNally K, et al. Preoperative evaluation and surgical management of infants and toddlers with drug-resistant epilepsy. Neurosurg Focus. 2018;45:1-12.
Gowda S, Salazar F, Bingaman WE, Kotagal P, Lachhwani DL, Gupta A, et al. Surgery for catastrophic epilepsy in infants 6 months of age and younger. J Neurosurg Pediatrics. 2010;5:603-7.
Dunkley C, Kung J, Scott RC, Nicolaides P, Neville B, Aylett SE, et al. Epilepsy surgery in children under 3 years. Epilepsy Res. 2011;93:96-106.
Sugimoto T, Otsubo H, Hwang PA, Hoffman HJ, Jay V, Snead OC III. Outcome of epilepsy surgery in the first three years of life. Epilepsia. 1999;40:560-5.
Wyllie E, Comair YG, Kotagal P, Raja S, Ruggieri P. Epilepsy surgery in infants. Epilepsia. 1996;37:625-37.
Coryell J, Gaillard WD, Shellhaas RA, Grinspan ZM, Wirrell EC, Knupp KG, et al. Neuroimaging of early life epilepsy. Pediatrics. 2018;142:e20180672.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-81.
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, et al. The REDCap consortium: building an international community of software partners. J Biomed Inform. 2019;95:103208.
Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):522-30.
Engel J, Van Ness P, Rasmussen T, Ojemann I. Outcome with respect to epileptic seizures. In: Engel J Jr, editor. Surgical treatment of the epilepsies. 2nd ed. New York, NY: Raven Press; 1993. p. 609-21.
Gracia CG, Yardi R, Kattan MW, Nair D, Gupta A, Najm I, et al. Seizure freedom score: a new simple method to predict success of epilepsy surgery. Epilepsia. 2015;56:359-565.
Karsonovich T, Alexander A, Graber S, O'Neil BR. Placement of leads for stereotactic electroencephalography without the use of anchor bolts: technical note. J Neurosurg Pediatr. 2020;18:1-6.
Taussig D, Dorfmüller G, Fohlen M, Jalin C, Bulteau C, Ferrand-Sorbets S, et al. Invasive explorations in children younger than 3 years. Seizure. 2012;21:631-8.
Taussig D, Chipaux M, Fohlen M, Dorison N, Bekaert O, Ferrand-Sorbets S, et al. Invasive evaluation in children (SEEG vs subdural grids). Seizure. 2020;77:43-51.
Liu Y, Chen G, Chen J, Zhou J, Su L, Zhao T, et al. Individualized stereoelectroencephalography evaluation and navigated resection in medically refractory pediatric epilepsy. Epilepsy Behav. 2020;112:107398.
Kim LH, Parker JJ, Ho AL, Pendharkar AV, Sussman ES, Halpern CH, et al. Postoperative outcomes following pediatric intracranial electrode monitoring: a case for stereoelectroencephalography (SEEG). Epilepsy Behav. 2020;104(pt A):106905.
Roberts JI, Hrazdil C, Wiebe S, Sauro K, Hanson A, Federico P, et al. Feasibility of using an online tool to assess appropriateness for an epilepsy surgery evaluation. Neurology. 2014;83:913-9.
Pulsifer MB, Brandt J, Salorio CF, Vining EPG, Carson BS, Freeman JM. The cognitive outcome of hemispherectomy in 71 children. Epilepsia. 2004;45:243-54.
Freitag H, Tuxhorn I. Cognitive function in preschool children after epilepsy surgery: rationale for early intervention. Epilepsia. 2005;46(4):561-7.

Auteurs

Michael Scott Perry (MS)

Justin Neuroscience Center, Cook Children's Medical Center, Fort Worth, Texas, USA.

Sabrina Shandley (S)

Justin Neuroscience Center, Cook Children's Medical Center, Fort Worth, Texas, USA.

Max Perelman (M)

Doernbecher Children's Hospital, Oregon Health Science Center, Oregon Health and Sciences University, Portland, Oregon, USA.

Rani K Singh (RK)

Division of Neurology, Department of Pediatrics, Atrium Health/Levine Children's Hospital, Charlotte, North Carolina, USA.

Lily Wong-Kisiel (L)

Divisions of Child Neurology and Epilepsy, Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

Joseph Sullivan (J)

Benioff Children's Hospital, University of California, San Francisco Weill Institute for Neurosciences, San Francisco, California, USA.

Ernesto Gonzalez-Giraldo (E)

Benioff Children's Hospital, University of California, San Francisco Weill Institute for Neurosciences, San Francisco, California, USA.

Erin Fedak Romanowski (EF)

Division of Pediatric Neurology, Department of Pediatrics, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Nancy A McNamara (NA)

Division of Pediatric Neurology, Department of Pediatrics, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Ahmad Marashly (A)

Division of Pediatric Neurology, University of Washington/Seattle Children's Hospital, Seattle, Washington, USA.

Adam P Ostendorf (AP)

Department of Pediatrics, Nationwide Children's Hospital, Ohio State University, Columbus, Ohio, USA.

Allyson Alexander (A)

Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Division of Pediatric Neurosurgery, Children's Hospital Colorado, Aurora, Colorado, USA.

Krista Eschbach (K)

Department of Neurology, Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.

Jeffrey Bolton (J)

Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.

Steven Wolf (S)

Boston Children's Health Physicians of New York and Connecticut, Maria Fareri Children's Hospital, New York Medical College, Valhalla, New York, USA.

Patricia McGoldrick (P)

Boston Children's Health Physicians of New York and Connecticut, Maria Fareri Children's Hospital, New York Medical College, Valhalla, New York, USA.

Dewi F Depositario-Cabacar (DF)

Center for Neuroscience, Children's National Hospital, George Washington University School of Medicine, Washington, District of Columbia, USA.

Michael A Ciliberto (MA)

Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA.

Satyanarayana Gedela (S)

Department of Pediatrics, Emory University College of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.

Kumar Sannagowdara (K)

Department of Pediatric Neurology, Children's Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Samir Karia (S)

Department of Neurology, Norton Children's Hospital, University of Louisville School of Medicine, Louisville, Kentucky, USA.

Daniel W Shrey (DW)

Children's Hospital of Orange County, Orange, California, USA.

Priya Tatachar (P)

Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA.

Srishti Nangia (S)

Weill-Cornell Medicine, New York, New York, USA.

Zachary Grinspan (Z)

Weill-Cornell Medicine, New York, New York, USA.

Shilpa B Reddy (SB)

Department of Pediatric Neurology, Monroe Carell Jr. Children's Hospital, Vanderbilt University, Nashville, Tennessee, USA.

Patel Shital (P)

Department of Pediatric Neurology, Monroe Carell Jr. Children's Hospital, Vanderbilt University, Nashville, Tennessee, USA.

Jason Coryell (J)

Doernbecher Children's Hospital, Oregon Health Science Center, Oregon Health and Sciences University, Portland, Oregon, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH